Safety and Efficacy Study of Hetrombopag Olamine in Chronic Idiopathic Thrombocytopenic Purpura (ITP) Patients

NCT02614846 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

29

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Idiopathic Thrombocytopenic Purpura

Interventions

DRUG: Hetrombopag Olamine

Sponsor

Jiangsu HengRui Medicine Co., Ltd.